CORMEDIX INC. Current Liabilities
CORMEDIX INC. (CRMD) had Current Liabilities of $187.40 million as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:LiabilitiesCurrent · last filed 2026-08-13
- 2026-06-30: Liabilities, Current $187.40M.
- 2026-03-31: Liabilities, Current $128.78M.
- 2025-12-31: Liabilities, Current $174.27M.
- 2025-09-30: Liabilities, Current $133.64M.
| Period end | Liabilities, Current | Liabilities, Current as first filed |
|---|---|---|
| 2026-06-30 | $187.40M 10-Q · filed 2026-08-13 | |
| 2026-03-31 | $128.78M 10-Q · filed 2026-05-14 | |
| 2025-12-31 | $174.27M 10-Q · filed 2026-08-13 | |
| 2025-09-30 | $133.64M 10-Q · filed 2025-11-12 | |
| 2025-06-30 | $31.71M 10-Q · filed 2025-08-07 | |
| 2025-03-31 | $34.39M 10-Q · filed 2025-05-06 | |
| 2024-12-31 | $33.84M 10-K · filed 2026-03-05 | $33.84M 10-K · filed 2025-03-25 |
| 2024-09-30 | $18.48M 10-Q · filed 2024-10-30 | |
| 2024-06-30 | $11.11M 10-Q · filed 2024-08-14 | |
| 2024-03-31 | $9.53M 10-Q · filed 2024-05-09 | |
| 2023-12-31 | $11.40M 10-K · filed 2025-03-25 | |
| 2023-09-30 | $7.67M 10-Q · filed 2023-11-14 | |
| 2023-06-30 | $7.39M 10-Q · filed 2023-08-08 | |
| 2023-03-31 | $4.67M 10-Q · filed 2023-05-15 | |
| 2022-12-31 | $6.31M 10-K · filed 2024-03-12 | |
| 2022-09-30 | $5.06M 10-Q · filed 2022-11-10 | |
| 2022-06-30 | $5.27M 10-Q · filed 2022-08-11 | |
| 2022-03-31 | $4.29M 10-Q · filed 2022-05-12 | |
| 2021-12-31 | $5.35M 10-K · filed 2023-03-30 | |
| 2021-09-30 | $5.21M 10-Q · filed 2021-11-09 | |
| 2021-06-30 | $3.12M 10-Q · filed 2021-08-12 | |
| 2021-03-31 | $3.05M 10-Q · filed 2021-05-13 | |
| 2020-12-31 | $4.16M 10-K · filed 2022-03-29 | |
| 2020-09-30 | $4.60M 10-Q · filed 2020-11-05 | |
| 2020-06-30 | $5.71M 10-Q · filed 2020-08-10 | |
| 2020-03-31 | $5.80M 10-Q · filed 2020-05-11 | |
| 2019-12-31 | $5.83M 10-K · filed 2021-03-30 | |
| 2019-09-30 | $5.01M 10-Q · filed 2019-11-14 | |
| 2019-06-30 | $4.35M 10-Q · filed 2019-08-14 | |
| 2019-03-31 | $4.33M 10-Q · filed 2019-05-13 | |
| 2018-12-31 | $7.77M 10-K · filed 2020-03-16 | |
| 2018-09-30 | $17.55M 10-Q · filed 2018-11-14 | |
| 2018-06-30 | $12.40M 10-Q · filed 2018-08-14 | |
| 2018-03-31 | $8.77M 10-Q · filed 2018-05-15 | |
| 2017-12-31 | $6.26M 10-K · filed 2019-05-29 | |
| 2017-09-30 | $4.25M 10-Q · filed 2017-11-09 | |
| 2017-06-30 | $5.79M 10-Q · filed 2017-08-09 | |
| 2017-03-31 | $3.89M 10-Q · filed 2017-05-10 | |
| 2016-12-31 | $4.09M 10-K · filed 2018-03-19 | |
| 2016-09-30 | $5.04M 10-Q · filed 2016-11-09 | |
| 2016-06-30 | $3.12M 10-Q · filed 2016-08-04 | |
| 2016-03-31 | $3.06M 10-Q · filed 2016-05-10 | |
| 2015-12-31 | $3.06M 10-K · filed 2017-03-16 | |
| 2015-09-30 | $2.88M 10-Q · filed 2015-11-12 | |
| 2015-06-30 | $1.91M 10-Q · filed 2015-08-06 | |
| 2015-03-31 | $2.12M 10-Q · filed 2015-05-07 | |
| 2014-12-31 | $1.43M 10-K · filed 2016-03-15 | |
| 2014-09-30 | $1.23M 10-Q · filed 2014-11-13 | |
| 2014-06-30 | $1.18M 10-Q · filed 2014-08-14 | |
| 2014-03-31 | $1.12M 10-Q · filed 2014-05-15 | |
| 2013-12-31 | $1.67M 10-K · filed 2015-03-12 | |
| 2013-09-30 | $3.77M 10-Q/A · filed 2014-03-04 | $3.94M 10-Q · filed 2013-11-19 |
| 2013-06-30 | $2.42M 10-Q/A · filed 2014-03-04 | $2.58M 10-Q · filed 2013-08-14 |
| 2013-03-31 | $2.08M 10-Q/A · filed 2014-03-04 | $2.23M 10-Q · filed 2013-05-15 |
| 2012-12-31 | $1.48M 10-K · filed 2014-03-31 | $1.62M 10-K · filed 2013-03-27 |
| 2012-09-30 | $1.69M 10-Q/A · filed 2013-03-27 | $1.36M 10-Q · filed 2012-11-13 |
| 2012-06-30 | $1.17M 10-Q/A · filed 2012-09-06 | |
| 2012-03-31 | $1.60M 10-Q · filed 2012-05-15 | |
| 2011-12-31 | $1.21M 10-K/A · filed 2014-03-04 | $1.31M 10-K · filed 2012-03-19 |
| 2011-09-30 | $2.28M 10-Q · filed 2011-11-10 | |
| 2011-06-30 | $1.70M 10-Q · filed 2011-08-09 | |
| 2010-12-31 | $1.58M 10-K/A · filed 2012-04-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aquestive Therapeutics, Inc. (AQST) | United States | $0.606B | -6.67 |
| IMPACT BIOMEDICAL INC. (IBO) | United States | $0.611B | 66.47 |
| CytomX Therapeutics, Inc. (CTMX) | United States | $0.598B | -10.25 |
| Monopar Therapeutics (MNPR) | United States | $0.598B | -34.82 |
| Altimmune, Inc. (ALT) | United States | $0.593B | -6.43 |
| Neurogene Inc. (NGNE) | $0.625B | -4.46 | |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| ZEVRA THERAPEUTICS, INC. (ZVRA) | United States | $0.668B | 14.61 |